Sibutramine, a popular slimming drug, marketed in India under the brand names like Reductil, Meridia, and Sibutrex, was banned by the Drug Controller General of India (DCGI) on Friday.
The decision was taken after the expert panel appointed by DCGI revealed that the drug has potential to cause serious side effects such as heart attacks, strokes, and cardiac arrest among its users.
When contacted, a DCGI spokesman confirmed the news saying, “We have asked the Health Ministry to ban the drug completely from the market,” under section 26 A of the Drugs and Cosmetics Act."
He added, “We have suspended the import and manufacturing of the drug and its formulations with immediate effect.”